| Financial Year |
March 31 2023 |
| Monetary Funds |
56,283,355,000.00 |
| Held-for-trading Financial Assets |
10,431,168,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
39,030,536,000.00 |
| Advances to Suppliers |
5,961,382,000.00 |
| Other Receivables |
1,771,697,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
88,278,571,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,162,521,000.00 |
| Other Current Assets |
16,619,805,000.00 |
| Total Current Assets |
256,761,554,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,424,600,000.00 |
| Long-term Equity Investment |
15,811,251,000.00 |
| Investment Properties |
84,381,000.00 |
| Fixed Assetes |
147,738,433,000.00 |
| Under-construction Projects |
56,150,237,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
27,609,892,000.00 |
| R&D expenses |
1,776,968,000.00 |
| Goodwill |
65,914,000.00 |
| Long-Term Deferred and Prepaid Expenses |
587,701,000.00 |
| Deferred Income Tax Assets |
4,705,231,000.00 |
| Other Non-Current Assets |
24,000,867,000.00 |
| Sub-Total of Non-Current Assets |
290,341,407,000.00 |
| Total Assets |
547,102,961,000.00 |
| Short-Term Loans |
15,701,332,000.00 |
| Trading Financial liabilities |
62,268,000.00 |
| Notes Payable |
3,709,539,000.00 |
| Accounts Payable |
152,444,845,000.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,613,343,000.00 |
| Taxes Payable |
4,198,949,000.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
149,416,646,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,760,886,000.00 |
| Other Current Liabilities |
1,076,500,000.00 |
| Sub-Total of Current Liabilities |
373,839,362,000.00 |
| Long-term Loans |
8,611,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,109,619,000.00 |
| Other Non-Current Liabilities |
33,796,529,000.00 |
| Sub-Total of Non-Current Liabilities |
47,178,793,000.00 |
| Total Liabilities |
421,018,155,000.00 |
| Paid-In Capital(Or Share Stock) |
2,911,143,000.00 |
| Capital Surplus |
62,048,998,000.00 |
| Surplus Reserve |
6,838,541,000.00 |
| LESS:Treasury Stock |
1,809,920,000.00 |
| Undistributed Profits |
45,073,295,000.00 |
| Minority Stockholder's Interest |
10,508,223,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
115,576,583,000.00 |
| Owner's Equity（Stockholder's Equity） |
126,084,806,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
547,102,961,000.00 |
